Please login to the form below

Not currently logged in
Email:
Password:

Novella Clinical appoints Dr Chris Smyth to head European and Asian operations

He joins the Quintiles company from fellow CRO INC Research

Novella Clinical Quintiles Dr Chris SmythNovella Clinical has appointed Dr Chris Smyth as managing director for its European and Asian operations.  

Dr Smyth joins the Quintiles-owned contract research organisation from INC Research, where he most recently served as senior vice president of clinical development in that CRO's oncology division.  

He has more than 20 years research and development experience in the pharmaceutical industry, during which time he has led CROs and biopharmaceutical companies in both Europe and the US.  

Novella Clinical's chief operating officer Rob King said: "We are fortunate to have someone as experienced as Dr Smyth guiding our team and business objectives in Europe and Asia.  

"His depth of international leadership and oncology operations expertise will prove to be an invaluable resource as we continue to expand our services into new markets."

In his new role Dr Smyth will be based in Novella's European headquarters in Stevenage, England and he succeeds Elizabeth Edwards, who will now serve as executive vice president of global operations, overseeing Novella's clinical monitoring division.

17th March 2014

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anatomy Health

We are a health information design consultancy focused on developing simple, accessible and inclusive patient communications. From evaluating existing patient...

Latest intelligence

The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch
...

Infographics